Improving understanding and treatment of acute kidney injury
Official title: Clinical Core
Funded at University of Alabama at Birmingham · NIH-10915658 · Data updated 2026-11-12
This study is working to improve the understanding and treatment of acute kidney injury (AKI) by bringing together researchers and sharing important health data, so they can find better ways to help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project start | September 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $292,819 |
| NIH project number | 5U54DK137307-02 |
| Project ID | NIH-10915658 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk for or diagnosed with acute kidney injury.
✕Less likely to help
Patients with chronic kidney disease or those not at risk for acute kidney injury may not benefit from this research.
What this research studies
This research focuses on acute kidney injury (AKI), a serious health issue affecting patient outcomes and healthcare resources. It aims to create a collaborative infrastructure that allows researchers to access clinical data, biorepositories, and advanced bioinformatics tools to better understand and treat AKI. By facilitating the sharing of electronic health records and other data, the project seeks to translate laboratory discoveries into practical applications that can improve patient care. The initiative emphasizes personalized medicine approaches to address the complexities of AKI.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for patients suffering from acute kidney injury.
How similar studies have gone: Previous research has shown promise in using collaborative data approaches to improve outcomes in similar conditions, indicating a potential for success in this novel initiative.
Where this research is happening
-
University of Alabama at Birmingham
Birmingham, United States Active
Researchers
- Principal investigator: Neyra, Javier a. — University of Alabama at Birmingham
- Study coordinator: Neyra, Javier a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.